UnitedHealth Group (NYSE: UNH) recently reported its Q3 results, with revenues and earnings exceeding our expectations.
UnitedHealth Group's stock fell 8.1% despite beating Q3 estimates due to conservative 2024 and 2025 EPS guidance. Find out ...
The UNH stock performance is affected by management’s full-year 2024 outlook of $15.50 to $15.75 per share in net income, ...
Is UnitedHealth stock a buy, sell or hold? Heading into Tuesday's trading, UnitedHealth Group stock was up 16.4% on a total ...
We recently compiled a list of 10 Safe Stocks To Invest In For The Long Term in 2024. In this article, we will look at where ...
We recently compiled a list of the Jim Cramer is Talking About These 14 Stocks Before Earnings. In this article, we are going ...
Mizuho Securities analyst Ann Hynes has assigned their bullish stance on UNH stock, giving a Buy rating today. Ann Hynes has given her Buy ...
What Are The Key Trends To Drive UnitedHealth’s Q3 Results? UnitedHealth should continue to benefit from an increase in total ...
Zacks.com on MSN2d
UnitedHealth Group (UNH) Q3 Earnings and Revenues Top EstimatesUnitedHealth (UNH) delivered earnings and revenue surprises of 1.85% and 1.31%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on UnitedHealth (UNH – Research Report) today and set a price target of ...
Investor's Business Daily on MSN2d
UNH Stock Inflicts 299-Point Hit On Dow Jones As High Costs Weigh On OutlookUnitedHealth earnings topped forecasts, but the Dow Jones member lowered the top end of its full-year outlook.
Elevance Health (ELV) shares fall 12% as full-year earnings forecast is lowered due to high medical expenses, impacting the managed care industry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback